Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand?
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-08-01
|
| Series: | General Psychiatry |
| Online Access: | https://gpsych.bmj.com/content/34/4/e100561.full |
| _version_ | 1819152865154826240 |
|---|---|
| author | Zahraa Jalal Vibhu Paudyal Ruba Saleh Azfr Ali |
| author_facet | Zahraa Jalal Vibhu Paudyal Ruba Saleh Azfr Ali |
| author_sort | Zahraa Jalal |
| collection | DOAJ |
| first_indexed | 2024-12-22T14:56:05Z |
| format | Article |
| id | doaj.art-57a14206eedc40d19bcdf9629329aed6 |
| institution | Directory Open Access Journal |
| issn | 2517-729X |
| language | English |
| last_indexed | 2024-12-22T14:56:05Z |
| publishDate | 2021-08-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | General Psychiatry |
| spelling | doaj.art-57a14206eedc40d19bcdf9629329aed62022-12-21T18:22:13ZengBMJ Publishing GroupGeneral Psychiatry2517-729X2021-08-0134410.1136/gpsych-2021-100561Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand?Zahraa Jalal0Vibhu Paudyal1Ruba Saleh Azfr Ali2School of Pharmacy, University of Birmingham, Birmingham, UKSchool of Pharmacy, University of Birmingham, Birmingham, UKClinical Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabiahttps://gpsych.bmj.com/content/34/4/e100561.full |
| spellingShingle | Zahraa Jalal Vibhu Paudyal Ruba Saleh Azfr Ali Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand? General Psychiatry |
| title | Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand? |
| title_full | Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand? |
| title_fullStr | Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand? |
| title_full_unstemmed | Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand? |
| title_short | Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand? |
| title_sort | guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications where do we stand |
| url | https://gpsych.bmj.com/content/34/4/e100561.full |
| work_keys_str_mv | AT zahraajalal guidelinesversuspracticeinscreeningandmonitoringofcardiometabolicrisksinpatientstakingantipsychoticmedicationswheredowestand AT vibhupaudyal guidelinesversuspracticeinscreeningandmonitoringofcardiometabolicrisksinpatientstakingantipsychoticmedicationswheredowestand AT rubasalehazfrali guidelinesversuspracticeinscreeningandmonitoringofcardiometabolicrisksinpatientstakingantipsychoticmedicationswheredowestand |